Protein A Resin Market
Global Protein A Resin Market Size, Share Forecast to 2030
[London, United Kingdom] – [1st June 2023]: The global protein A resin market size is expected to reach USD 2.1 billion by 2028, according to a new report by Pharmanucleus. The market is projected to grow at a CAGR of 9.8% from 2023 to 2030.
The growth of the protein A resin market is attributed to the increasing demand for monoclonal antibodies (mAbs) in the treatment of various diseases, such as cancer, autoimmune disorders, and infectious diseases. MAbs are produced using protein A resins, which are highly efficient in purifying mAbs from cell culture supernatants.
The antibody purification segment is expected to be the largest segment of the protein A resin market during the forecast period. This is due to the increasing demand for mAbs in the treatment of various diseases. The immunoprecipitation segment is expected to be the fastest-growing segment during the forecast period. This is due to the increasing use of protein A resins in the research and development of new drugs and vaccines.
The biopharmaceutical companies segment is expected to be the largest segment of the protein A resin market during the forecast period. This is due to the high demand for protein A resins in the production of mAbs. The biotechnology companies segment is expected to be the fastest-growing segment during the forecast period. This is due to the increasing use of protein A resins in the research and development of new drugs and vaccines.
North America is expected to be the largest market for protein A resins during the forecast period. This is due to the presence of a large number of biopharmaceutical and biotechnology companies in the region. Europe and Asia Pacific are expected to be the fastest-growing markets during the forecast period. This is due to the increasing demand for mAbs in the treatment of various diseases in these regions.
Some of the key players in the protein A resin market include Thermo Fisher Scientific Inc., GE Healthcare Life Sciences, MilliporeSigma, Repligen Corporation, and Bio-Rad Laboratories. These companies are focusing on developing new products and technologies to expand their market share.
For more information about the report and to request a sample copy, please visit
Contact Us:
John.M
Business Consultant
john.m@pharmanucleus.com
Support: +44 (0)20 8470 4967
https://www.pharmanucleus.com/
About Pharmanucleus
Pharma Nucleus is a market research company that provides clients access to custom, syndicated reports and consulting on one platform. As a company with rich knowledge in analysis and research across healthcare domains, such as pharma, medical device and biotechnology. Insights derived from Pharma Nucleus help life sciences and other healthcare organizations accelerate the launch, development, and dissemination of life-saving therapies, navigate significant attention with key opinion leaders, and help ensure equitable access to healthcare services.